Catalyst Event

Medtronic PLC (MDT) · Other

From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)

3/23/2026, 12:00:00 AM

OtherSentiment: Positive

On March 23, 2026, Medtronic announced it received FDA approval for an expanded indication for its OmniaSecure™ defibrillation lead for use in conduction system pacing.

Korean Translation

2026년 3월 23일, 메드트로닉은 자사의 옴니아시큐어(OmniaSecure™) 제세동기 리드가 전도 시스템 페이싱(conduction system pacing)에 사용되도록 적응증 확대에 대해 FDA 승인을 받았다고 발표함.

Related Recent Events

View Full Timeline